Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542838PMC
http://dx.doi.org/10.3324/haematol.2022.282220DOI Listing

Publication Analysis

Top Keywords

kir3dl2 represent
4
represent novel
4
novel therapeutic
4
therapeutic target
4
target aggressive
4
aggressive systemic
4
systemic peripheral
4
peripheral t-cell
4
t-cell lymphoma
4
kir3dl2
1

Similar Publications

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic and debilitating disease with unknown cause. Involvement of infection and immune dysregulation has been suggested, including changes in immune cell subsets and abnormal functions of natural killer (NK) cells. The regulatory NK cell receptors, killer cell immunoglobulin-like receptors (KIR) have previously been investigated in small cohorts of ME/CFS patients with conflicting results regarding gene content.

View Article and Find Full Text PDF

Introduction: CAR T cell therapy provided transformative outcomes for patients with B-cell lymphoma; however, a large fraction of patients remains at risk for relapse, underlying the need to uncover mechanisms of resistance and predictive biomarkers. Herein, we leveraged the ZUMA-7 phase III randomized trial of relapsed/refractory large B-cell lymphoma (LBCL) patients treated with axicabtagene ciloleucel (axi-cel; CD19-targeting CAR T cells) to discover tumor gene expression signatures (GES) associated with outcome.

Methods: With tumor transcriptomics from 134 axi-cel patients, we employed multivariate penalized Cox models analyzing event-free survival (EFS), progression-free survival (PFS), and duration of response (DOR).

View Article and Find Full Text PDF

KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.

Haematologica

October 2023

Paris-Est Créteil University (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, F-94010, Créteil, France; Henri Mondor hospital, AP-HP, Department of Pathology, F-94010, Créteil.

View Article and Find Full Text PDF
Article Synopsis
  • - The study focuses on identifying the interactions between rhesus macaque killer cell Ig-like receptors (KIRs) and MHC class I molecules, which is crucial for understanding natural killer (NK) cell biology in these primates as they serve as important animal models for various fields.
  • - Researchers tested rhesus macaque KIRs against different MHC class I alleles and discovered 12 KIRs with previously unknown specificities, categorizing their interactions primarily into three groups: those that bind to Mamu-Bw4, Mamu-A-related molecules, and Mamu-A1*012:01.
  • - Most KIRs interacting with Mamu-Bw4 were inhibitory, while those binding to Mamu
View Article and Find Full Text PDF

Background: Natural killer (NK) cells represent a critical component of the innate immune system's response against cancer and viral infections, among other diseases. To distinguish healthy host cells from infected or tumor cells, killer immunoglobulin receptors (KIR) on NK cells bind and recognize Human Leukocyte Antigen (HLA) complexes on their target cells. However, NK cells exhibit great diversity in their mechanism of activation, and the outcomes of their activation are not yet understood fully.

View Article and Find Full Text PDF